Setoperone

This classification denotes an anxiolytic with the molecular formula C21H24FN3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BQ67CS3Q3E, chemically known as 6-(2-(4-(p-fluorobenzoyl)piperidino)ethyl)-2,3-dihydro-7-methyl-5h-thiazolo(3,2-a)pyrimidin-5-one but generally known as setoperone, which bears US NIH Compound Identifier 68604. European Medicines Agency schedules Setoperone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10504MIG. The term SETOPERONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). SETOPERONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule setoperone under HS 29349990 and SITC 51579. As of Q4 2014, SETOPERONE remains the US FDA Preferred Term for this commodity. Setoperone bears US NLM identifiers UMLS ID C0074411 and NCI Concept Code C73296. SMILES: S1C2N(C(=O)C(CCN3CCC(CC3)C(=O)C3CCC(F)CC3)C(N2)C)CC1.